[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$iugnf
Imugene's azer-cel shows strong results in Phase 1b trial for DLBCL. Investors are anticipating an FDA meeting for further discussion and news.
About $iugnf
Imugene (IUGNF) is a stock ticker symbol for a biotechnology company.
Insights #
- $iugnf creators is up XXX% from the previous week.
- $iugnf mentions is up XXX% from the previous week.
Engagements: X #
Engagements 24-Hour Chart Data
Current Value: X
Daily Average: XX
1 Week: XX -XX%
1 Month: XXX -XX%
1-Year High: XXX on 2025-05-30
1-Year Low: X on 2025-05-31
| Social Network | X |
|---|---|
| Engagements | X |
Mentions: X #
Mentions 24-Hour Chart Data
Current Value: X
Daily Average: X
1 Week: X +150%
1 Month: X -XX%
1-Year High: XX on 2025-05-30
1-Year Low: X on 2025-05-04
| Social Network | X |
|---|---|
| Mentions | X |
Creators: X #
Creators 24-Hour Chart Data
X unique social accounts have posts mentioning $iugnf in the last XX hours which is no change from in the previous XX hours
Daily Average: X
1 Week: X +100%
1 Month: X -XX%
1-Year High: X on 2025-05-30
1-Year Low: X on 2025-05-04
Top topics mentioned In the posts about $iugnf in the last XX hours